GCA
PFE icon

Gallagher Capital Advisors’s Pfizer PFE Stock Holding History

Gallagher Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.09M Buy
143,311
+2,069
+1% +$55K 2.19% 14
2026
Q2 		$3.4M Buy
141,242
+1,495
+1% +$39.1K 1.94% 18
2026
Q1 		$3.92M Buy
139,747
+1,069
+0.8% +$28.5K 2.56% 14
2025
Q4 		$3.45M Sell
138,678
-8,569
-6% -$216K 2.23% 15
2025
Q3 		$3.62M Buy
147,247
+1,119
+0.8% +$27.6K 2.09% 15
2025
Q2 		$3.54M Sell
146,128
-3,257
-2% -$76K 2.86% 12
2025
Q1 		$3.79M Sell
149,385
-3,228
-2% -$84.5K 2.88% 11
2024
Q4 		$4.05M Buy
+152,613
New +$4.14M 2.95% 11

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Gallagher Capital Advisors's PFE Position: Q3 2026 in Review

Gallagher Capital Advisors increased its Pfizer (PFE) stake by 1.5% in Q3 2026, buying an estimated $55K and bringing the position to 143,311 shares worth $4.09M. The position accounts for 2.19% of the portfolio, ranked #14.

Gallagher Capital Advisors first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Gallagher Capital Advisors held 143,311 shares of Pfizer worth $4.09M as of Q3 2026.
  • Gallagher Capital Advisors bought 2,069 Pfizer shares in Q3 2026, an estimated $55K.
  • Pfizer made up 2.19% of Gallagher Capital Advisors's portfolio in Q3 2026, its #14 holding.
  • Gallagher Capital Advisors first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Gallagher Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.